The effect of adjunctive subantimicrobial dose doxycycline therapy on GCF EMMPRIN levels in chronic periodontitis

Journal of Periodontology

Volumn 79, Issue 3, 2008, Pages 469-476

  Emingil, Gülnur ^a   Atilla, Gül ^a   Sorsa, Timo ^b   Tervahartiala, Taina ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Doxycycline; EMMPRIN; Gingival crevicular fluid; Matrix metalloproteinases; Root planing

Indexed keywords

ANTIINFECTIVE AGENT; CD147 ANTIGEN; DOXYCYCLINE;

ADULT; ARTICLE; CHEMISTRY; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PERIODONTICS; PERIODONTITIS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE; WESTERN BLOTTING;

ADULT; ANTI-BACTERIAL AGENTS; ANTIGENS, CD147; BLOTTING, WESTERN; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DENTAL PLAQUE INDEX; DENTAL SCALING; DOUBLE-BLIND METHOD; DOWN-REGULATION; DOXYCYCLINE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; STATISTICS, NONPARAMETRIC;

EID: 41449089786     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070165     Document Type: Article

References (53)

1. Bartold PM, Narayanan AS. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol 2000 2006;40:29-49.
2. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-318.
3. McCawley LJ, Matrisian LM. Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 2001;13:534-540.
4. Sorsa T, Tjaderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321.
5. Page-McCaw A, Ewald AJ, Werb Z. Matrix metal-loproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007;8:221-233.
6. Biswas C, Zhang Y, DeCastro R, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995;55:434-439.
7. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997;272:24-27.
8. Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001;158:1921-1928.
9. Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metal-loproteinase inducer interactions. Cancer Res 2001; 61:2276-2281.
10. Kataoka H, DeCastro R, Zucker S, Biswas C. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993;53:3154-3158.
11. Kinane DF, Attström R. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontol 2005;32:130-131.
12. Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 1999;28:520-526.
13. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue break-down by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
14. Golub LM, Ramamurthy NS, McNamara TF. Tetracy-clines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-322.
15. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, Payonk GS. Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent Assoc 1994; 125:163-171.
16. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330.
17. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS. A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann N Y Acad Sci 1994;732:96-111.
18. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
19. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-1314.
20. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001 ; 28:146-156.
21. Golub LM, Sorsa T, Lee H-M, et ai. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995;22:100-109.
22. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 2004;75:106-115.
23. Caton JG, Ciancio SG, Blieden TM, et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532.
24. Choi D, Moon I-S, Choi B-K, et al. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res 2004;39:20-26.
25. Lee JY, Lee YM, Shin SY, et al. Effect of subantimicrobial dose doxycycline as an effective adjunct to scaling and root planing. J Periodontol 2004;75:1500-1508.
26. Emingil G, Gürkan A, Atilla G, Berdeli A, Çinarcik S. Adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid tissue plasminogen activator levels in chronic periodontitis. Inflamm Res 2006;55:550-558.
27. Gabison EE, Xuan TH, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005;87:361-368.
28. DeCastro R, Zhang Y, Guo H, et al. Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol 1996;106: 1260-1265.
29. Maatta M, Tervahartiala T, Kaarniranta K, et al. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr Eye Res 2006;31:917-924.
30. Konttinen YT, Li TF, Mandelin J, et al. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 2000; 43:275-280.
31. Cao Z, Xiang J, Li C. A potential role of EMMPRIN by regulating ECM degradation in periodontitis. Med Hypotheses 2007;69:1102-1104.
32. Emingil G, Tervahartiala T, Mãntylã P, Määttä M, Sorsa T, Atilla G. Gingival crevicular fluid matrix metalloproteinase-7, extracellular matrix metalloproteinase inducer (EMMPRIN) and tissue inhibitor of MMP (TIMP)-1 levels in periodontal disease. J Periodontal 2006;77:2040-2050.
33. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontal 1999;4:1-6.
34. Löe H, Silness J. Periodontal disease in pregnancy. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
35. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of vitamin C. J Periodontol 1970;41:41 -43.
36. Lamster IB, Hartley LJ, Oshrain RL. Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips. Arch Oral Biol 1985;30:235-242.
37. Cimasoni G. Method of collection. In: Crevicular Fluid Updated. Basel, Switzerland: S. Karger; 1983:29-36.
38. Greenstein G. Periodontal response to mechanical non-surgical therapy: A review. J Periodontol 1992; 63:118-130.
39. Kinane DF, Chestnutt IG. Smoking and periodontal disease. Crit Rev Oral Biol Med 2000;11:356-365.
40. Nordskog BK, Blixt AD, Morgan WT, Fields WR, Hellman GM. Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc Toxicol 2003;3:101-117.
41. Palmer RM, Wilson RF, Hasan AS, Scott DA. Mechanisms of action of environmental factors - Tobacco smoking. J Clin Periodontol 2005;32:180-195.
42. Preshaw PM, Hefti AF, Novak MJ, et al. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: A multicenter trial. J Periodontol 2004;75:1068-1076.
43. Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MK. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. J Clin Periodontal 2004;31:697-707.
44. Hujoel PP, Baab DA, DeRouen TA. Measures of treatment efficacy. J Clin Periodontol 1993;20:601-605.
45. Caton JG, Ciancio SG, Blieden TM, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: Post-treatment effects. J Clin Periodontol 2001;28:782-789.
46. Novak MJ, Johns LP, Miller RC, Bradshaw MH. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol 2002;73:762-769.
47. Gürkan A, Çinarcik S, Hüseyinov A. Adjunctive sub-antimicrobial dose doxycycline: Effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis. J Clin Periodontol 2005;32:244-253.
48. Crout RJ, Lee HM, Schroeder K, et al. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: A preliminary study. J Periodontol 1996;67:506-514.
49. Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992;2:80-90.
50. Ingman T, Sorsa T, Suomalainen K, et al. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol 1993;64:82-88.
51. Demirel K, Baer PN, McNamara TF. Topical application of doxycycline on periodontally involved root surfaces in vitro: Comparative analysis of substantivity on cementum and dentin. J Periodontol 1991;62:312-316.
52. Michalowicz BS, Pihlstrom BL, Drisko CL, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Maintenance response. J Periodontol 1995;66:708-715.
53. Caton JG, Ciancio SG, Blieden TM, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: Post-treatment effects. J Clin Periodontol 2001;28:782-789.